Sera Prognostics is Named a 2017 Silver Edison Award Winner
April 21, 2017 07:00 ET
|
Sera Prognostics, Inc.
NEW YORK, April 21, 2017 (GLOBE NEWSWIRE) -- The Edison Awards, celebrating 30 years of honoring the best in innovation and excellence in the development of new products and services, announced...
Research on Fetal Sex Differences in Predicting Spontaneous Preterm Birth Using Sera’s Proteomic Technology to be Presented at The 64th Annual Society for Reproductive Investigation Meeting
March 13, 2017 14:00 ET
|
Sera Prognostics, Inc.
SALT LAKE CITY, March 13, 2017 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, today announced that research using Sera’s innovative proteomic technology platform that...
Sera Prognostics’ PreTRM® Named Edison Awards Finalist
February 09, 2017 12:50 ET
|
Sera Prognostics, Inc.
SALT LAKE CITY, Feb. 09, 2017 (GLOBE NEWSWIRE) -- Sera Prognostics, a women’s heath company, today announced that PreTRM®, the first and only clinically-validated blood test that provides an early...
Research on Underlying Mechanisms of Pregnancy Complications and Medical Interventions Using Sera’s Proteomic Technology to be Presented at the Society for Maternal-Fetal Medicine’s 37th Annual Pregnancy Meeting
January 23, 2017 15:08 ET
|
Sera Prognostics, Inc.
SALT LAKE CITY, Jan. 23, 2017 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, today announced the presentation of ongoing research evaluating the underlying mechanisms of...
Sera Prognostics Enters into Agreement with LabCorp to be the Exclusive U.S. Distributor of PreTRM® Test
January 10, 2017 07:00 ET
|
Sera Prognostics, Inc.
SALT LAKE CITY, Jan. 10, 2017 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a woman’s healthcare company, announced today that it has entered into a strategic collaboration with Laboratory Corporation...
Sera Prognostics to Present at 35th Annual J.P. Morgan Healthcare Conference
January 03, 2017 10:00 ET
|
Sera Prognostics, Inc.
SALT LAKE CITY, Jan. 03, 2017 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, today announced that Gregory C. Critchfield, M.D., M.S., Chairman and Chief Executive Officer,...
Two Peer-Reviewed Publications Highlight Clinical Utility of PreTRM® Test
December 19, 2016 09:00 ET
|
Sera Prognostics, Inc.
SALT LAKE CITY, Dec. 19, 2016 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, today announced the recent publication of two reports showing significant clinical utility of...
Sera Prognostics to Present at 28th Annual Piper Jaffray Healthcare Conference
November 21, 2016 07:00 ET
|
Sera Prognostics, Inc.
SALT LAKE CITY, Nov. 21, 2016 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, today announced that Gregory C. Critchfield, M.D., M.S., Chairman and Chief Executive Officer,...
Sera Prognostics to Present at Ladenburg Thalmann 2016 Healthcare Conference
September 20, 2016 11:36 ET
|
Sera Prognostics, Inc.
SALT LAKE CITY, Sept. 20, 2016 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, today announced that Gregory C. Critchfield, M.D., M.S., Chairman and Chief Executive...
Landmark Study Published in American Journal of Obstetrics & Gynecology Validates New Blood Test as Objective, Predictive Tool for Preterm Birth Risk
March 10, 2016 07:00 ET
|
Sera Prognostics, Inc.
SALT LAKE CITY, March 10, 2016 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, today announced that clinical validation data from the 5,501 patient Proteomic Assessment of...